Tagged with M

Cegedim Mexico From your perspective in healthcare consultancy at CEGEDIM, what do you think have been the most impactful changes in the Mexican pharmaceutical and healthcare sector over the last few years? One of the most important issues that changed in the Mexican pharmaceutical industry is the growth of generics, and this…

Latam Clinical Trials While LatAm originally emerged from the SIPLAS organization, how was it evolved since then to be where it is today? LatAm was born in 2000 as a business unit of SIPLAS labs and was known at the time as SIPLAS Research Organization. We decided to change our name to LatAm…

Hutchison Medipharma You began your career at Pfizer, working your way up the organizational ladder, when suddenly you decided to come to China back in 2001, well before China was on the map for R&D. What drove you to make this choice, to take the risk and come to China? It wasn’t…

Maver Maver has an impressive track record in developing and commercializing blockbuster products for the Chilean market, such as Tapsin and Disfruta, which today are the #1 brands in their categories. What would you say has been your recipe for success? I believe our success is based on our targeted marketing…

Boehringer Ingelheim Chile What have been Boehringer Ingelheim’s major milestones and achievements since your establishment in Chile? Chile, in the regional context, represents a very important market with a solid evolution in terms of sales. For our company, on a regional scale, the country has been growing above the average rate of 15.6%…

Luye Pharma What was the transition like from academia into entrepreneurship and what challenges did you face in beginning this company? I realized during this period in the late 1980s that there were no local Chinese companies doing what I wanted to do at the time so I saw there was an…

Merck Serono China As growth has stalled in Europe, the US and Japan, many multinational companies are looking at China as part of a hedging strategy and a key growth driver of the future. You must be feeling a lot of pressure from company headquarters as well as the natural pressures of working…

China Pharmaceutical Enterprises Association First, let me briefly introduce myself. I used to work in Fuxin, a small city in the industrially advanced province of Liaoning which is equivalent to a state in the US. I worked in a company’s pharmaceutical factory for twenty years holding various positions such as technology director, factory head,…

Fountain Medical Development You have an MD and you’ve worked in industry, but then you decided to become and entrepreneur. What challenges did you face in transitioning to starting your own company and in growing your organization? Entrepreneurship is nothing new in China. Half the population of this country seems to want to…

China Association of Traditional Chinese Medi You started the Chinese operations and have been working in the country for many years but recently moved up to running all operations in Asia Pacific. Are you still closely involved with what’s happening in China? I started the operations in China almost 16 years ago, and I started them…

Venturepharm Venturepharm is the most diversified company we’ve seen, throughout many verticals, taking a full-service plus model from venture capital, merchant banking, CRO, CMO, CSO, compound partnering to royalty sharing. That’s quite broad; what exactly is Venturepharm? The company is centred around our flagship CRO/CMO/CSO, and our positioning is similar to…

China Pharmaceutical Industry Association (CPIA) You have a very long history in the Chinese pharmaceutical industry, first in the joint venture company Xian-Janssen and then in the China National Pharmaceutical Group. Could you highlight the main evolutions of the Chinese pharmaceutical industry through these fast-changing times? It is indeed true that we have undergone tremendous…